상품명칭 |
16,16-디메틸프로스타글란딘 E2 |
별명 |
16,16-디메틸프로스타글란딘 E2; (5Z, 11- 알파, 13E, 15R) -11,15- 디 히드 록시 -16,16- 디메틸 -9- 옥소 프로스타 -5,13- 디엔 -1- 오익 산; 16,16- 디메틸 -pge2; 16,16- 디메틸 - 프로스타글란딘 E2; 5-헵텐산, 7-(2-(4,4-디메틸-3-히드록시-1-옥테닐)-3-히드록시-5-옥소사이클로펜틸)-; 7-(2-(4,4-디메틸-3-히드록시-1-옥테닐)-3-히드록시-5-옥소시클로펜틸)-5-헵텐산; BRN 2896843; 프로스타 -5,13- 디엔 -1- 오산, 11,15- 디 히드 록시 -16,16- 디메틸 -9- 옥소 -, (5Z, 11- 알파, 13E, 15R) -; (5E, 8beta, 11beta, 12xi, 13E, 15R) -11,15- 디 히드 록시 -16,16- 디메틸 -9- 옥소 프로스타 -5,13- 디엔 -1- 오익 산 |
영문 이름 |
16,16-dimethylprostaglandin E2;16,16-Dimethylprostaglandin E2; (5Z,11-alpha,13E,15R)-11,15-Dihydroxy-16,16-dimethyl-9-oxoprosta-5,13-dien-1-oic acid; 16,16-Dimethyl-pge2; 16,16-Dimethyl-prostaglandin E2; 5-Heptenoic acid, 7-(2-(4,4-dimethyl-3-hydroxy-1-octenyl)-3-hydroxy-5-oxocyclopentyl)-; 7-(2-(4,4-Dimethyl-3-hydroxy-1-octenyl)-3-hydroxy-5-oxocyclopentyl)-5-heptenoic acid; BRN 2896843; Prosta-5,13-dien-1-oic acid, 11,15-dihydroxy-16,16-dimethyl-9-oxo-, (5Z,11-alpha,13E,15R)-; (5E,8beta,11beta,12xi,13E,15R)-11,15-dihydroxy-16,16-dimethyl-9-oxoprosta-5,13-dien-1-oic acid |
분자식 |
C22H36O5 |
분자량 |
380.5182 |
InChI |
InChI=1/C22H36O5/c1-4-5-14-22(2,3)20(25)13-12-17-16(18(23)15-19(17)24)10-8-6-7-9-11-21(26)27/h6,8,12-13,16-17,19-20,24-25H,4-5,7,9-11,14-15H2,1-3H3,(H,26,27)/b8-6+,13-12+/t16-,17?,19-,20+/m0/s1 |
cas번호 |
39746-25-3 |
분자 구조 |
|
밀도 |
1.119g/cm3 |
비등점 |
541.3°C at 760 mmHg |
굴절 지수 |
1.551 |
인화점 |
295.2°C |
증기압 |
5.66E-14mmHg at 25°C |
위험성 표시 |
|
리스크 규칙 |
|
보안 규칙 |
|
|